No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Multicenter Study
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Area Under Curve
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Cytarabine / analogs & derivatives
-
Cytarabine / pharmacokinetics
-
Female
-
Half-Life
-
Humans
-
Idarubicin / administration & dosage
-
Idarubicin / adverse effects
-
Idarubicin / pharmacokinetics
-
Leukemia, Myeloid, Acute / drug therapy*
-
Male
-
Maximum Tolerated Dose
-
Middle Aged
-
Young Adult
Substances
-
Cytarabine
-
5'-oleoyl cytarabine
-
Idarubicin